SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-069683
Filing Date
2023-12-12
Accepted
2023-12-12 16:05:15
Documents
18
Period of Report
2023-12-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sndx-20231210.htm   iXBRL 8-K 41881
2 EX-99.1 sndx-ex99_1.htm EX-99.1 44321
3 EX-99.2 sndx-ex99_2.htm EX-99.2 36559
4 EX-99.3 sndx-ex99_3.htm EX-99.3 33645
5 GRAPHIC img199102934_0.jpg GRAPHIC 14374
6 GRAPHIC img200026455_0.jpg GRAPHIC 14374
7 GRAPHIC img200949976_0.jpg GRAPHIC 14360
  Complete submission text file 0000950170-23-069683.txt   363043

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sndx-20231210_pre.xml EX-101.PRE 10229
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sndx-20231210.xsd EX-101.SCH 2463
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sndx-20231210_lab.xml EX-101.LAB 13908
12 EXTRACTED XBRL INSTANCE DOCUMENT sndx-20231210_htm.xml XML 4869
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37708 | Film No.: 231481236
SIC: 2834 Pharmaceutical Preparations